Search Clinical Trials
608,149 trials
ID
Status
Phase
Title
Sponsor
NCT07891091
SUTURE TYPE AND RECURRENCE RISK AFTER INCISIONAL HERNIA REPAIRErsta DiakoniNot Yet RecruitingNot Applicable
NCT07891091Not Yet Recruiting
Not Applicable
SUTURE TYPE AND RECURRENCE RISK AFTER INCISIONAL HERNIA REPAIRErsta Diakoni
NCT07892677
Methadone Administration in Critically Ill Patients in the Intensive Care Unit and Risk of Prolonged QTc and Cardiac ArrythmiaMeir Medical CenterNot Yet Recruiting
NCT07892677Not Yet Recruiting
—
Methadone Administration in Critically Ill Patients in the Intensive Care Unit a...Meir Medical Center
NCT07892651
MENA/Levant Epidemiological, Registry of Immunological & Clinical Traits (MERIT)Axiom BioregistryNot Yet Recruiting
NCT07892651Not Yet Recruiting
—
MENA/Levant Epidemiological, Registry of Immunological & Clinical Traits (MERIT)Axiom Bioregistry
NCT07891897
Evaluation of the Agreement Between Automated Program-Operated Phoropter Subjective Refraction and Optometrist-Performed Subjective RefractionZhongshan Ophthalmic Center, Sun Yat-sen UniversityNot Yet RecruitingNot Applicable
NCT07891897Not Yet Recruiting
Not Applicable
Evaluation of the Agreement Between Automated Program-Operated Phoropter Subject...Zhongshan Ophthalmic Cent...
NCT07891169
Master Protocol for Basket Clinical Trials of Targeted Therapies Based on Proteome and Whole Exome Sequencing Screening in Patients With Advanced Solid TumorsNational Cancer Center, KoreaActive Not RecruitingNot Applicable
NCT07891169Active Not Recruiting
Not Applicable
Master Protocol for Basket Clinical Trials of Targeted Therapies Based on Proteo...National Cancer Center, K...
NCT07893106
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASC36 Tablets for Oral Use in Adult Participants With Obesity or OverweightAscletis Pharma (China) Co., LimitedRecruitingPhase 1
NCT07893106Recruiting
Phase 1
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodyna...Ascletis Pharma (China) C...
NCT07893145
Specialist Supportive Clinical Management (SSCM) for Children and Adolescents With Anorexia Nervosa and Atypical Anorexia NervosaKarolinska InstitutetRecruitingNot Applicable
NCT07893145Recruiting
Not Applicable
Specialist Supportive Clinical Management (SSCM) for Children and Adolescents Wi...Karolinska Institutet
NCT07892222
Stress Hyperglycemia Ratio and Glucose Variability in Critically Ill PatientsAssiut UniversityNot Yet Recruiting
NCT07892222Not Yet Recruiting
—
Stress Hyperglycemia Ratio and Glucose Variability in Critically Ill PatientsAssiut University
NCT07892755
Liquid Biopsy-Based Early Screening for Endometrial Cancer in Regional Chinese PopulationsGuizhou Provincial People's HospitalRecruiting
NCT07892755Recruiting
—
Liquid Biopsy-Based Early Screening for Endometrial Cancer in Regional Chinese P...Guizhou Provincial People...
NCT07893080
Ultrasound Mapping of the Anatomical Relationship Between the Right Internal Jugular Vein and Carotid ArteryAnkara City Hospital BilkentNot Yet Recruiting
NCT07893080Not Yet Recruiting
—
Ultrasound Mapping of the Anatomical Relationship Between the Right Internal Jug...Ankara City Hospital Bilk...
NCT07892378
Multiparametric Magnetic Resonance Imaging (mpMRI) Versus Prostate-Specific Membrane Antigen Positron Emission Tomography (PSMA-PET) for Detecting Clinically Significant Prostate Cancer in Transition Zone Lesions /PRostate Imaging With MRI and PET in the Transition Zone (PRIME-TZ)Sanatorio Privado San GeronimoNot Yet Recruiting
NCT07892378Not Yet Recruiting
—
Multiparametric Magnetic Resonance Imaging (mpMRI) Versus Prostate-Specific Memb...Sanatorio Privado San Ger...
NCT07891676
Scoliosis Treatment: Evaluating Patient SuitabilityXuanwu Hospital, BeijingNot Yet Recruiting
NCT07891676Not Yet Recruiting
—
Scoliosis Treatment: Evaluating Patient SuitabilityXuanwu Hospital, Beijing
NCT07891377
HEC53856 Tablets for Chemotherapy-induced Anemia in Non-myeloid MalignanciesSunshine Lake Pharma Co., Ltd.Not Yet RecruitingPhase 2
NCT07891377Not Yet Recruiting
Phase 2
HEC53856 Tablets for Chemotherapy-induced Anemia in Non-myeloid MalignanciesSunshine Lake Pharma Co.,...
NCT07893171
Study of CM529D1 in Participants With Advanced Solid TumorsKeymed Biosciences Co.LtdNot Yet RecruitingPhase 1
NCT07893171Not Yet Recruiting
Phase 1
Study of CM529D1 in Participants With Advanced Solid TumorsKeymed Biosciences Co.Ltd
NCT07891650
Personalized Intermittent Theta Burst Stimulation for Cognitive Impairment Related to Cerebral Small Vessel DiseaseMinistry of Science and Technology of the People´s Republic of ChinaNot Yet RecruitingNot Applicable
NCT07891650Not Yet Recruiting
Not Applicable
Personalized Intermittent Theta Burst Stimulation for Cognitive Impairment Relat...Ministry of Science and T...
NCT07891871
RE-RITE: Real-world Evaluation of Response, Implementation and Toxicity of ElranatamabPfizerNot Yet Recruiting
NCT07891871Not Yet Recruiting
—
RE-RITE: Real-world Evaluation of Response, Implementation and Toxicity of Elran...Pfizer
NCT07891390
Pilot Study to Determine the Optimal Protocol for Preoperative Transcutaneous Vagal NeurostimulationCentre Hospitalier Universitaire de Saint EtienneNot Yet RecruitingNot Applicable
NCT07891390Not Yet Recruiting
Not Applicable
Pilot Study to Determine the Optimal Protocol for Preoperative Transcutaneous Va...Centre Hospitalier Univer...
NCT07891832
Video Laryngeal Mask SaCoVLM Versus LMA Supreme and Ambu AuraGain in ChildrenCharles University, Czech RepublicNot Yet RecruitingNot Applicable
NCT07891832Not Yet Recruiting
Not Applicable
Video Laryngeal Mask SaCoVLM Versus LMA Supreme and Ambu AuraGain in ChildrenCharles University, Czech...
NCT07893340
First-line Treatment With Dual Immunotherapy Combined With Anti-angiogenesis for Unresectable Advanced Malignant Peritoneal MesotheliomaFudan UniversityNot Yet RecruitingPhase 2
NCT07893340Not Yet Recruiting
Phase 2
First-line Treatment With Dual Immunotherapy Combined With Anti-angiogenesis for...Fudan University
Result Breakdown
Not yet recruiting15 (75%)
Recruiting3 (15%)
Active, not recruiting1 (5%)
Unknown1 (5%)
Not Specified9 (45%)
not_applicable7 (35%)
Phase 12 (10%)
Phase 22 (10%)